Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment …

Objectives Aim of the study was to evaluate the prognostic impact of CD8-positive (CD8+)
tumour-infiltrating lymphocytes (TILs) and PD-L1 expression on the outcome of patients with …

Mammary analogue secretory carcinoma (MASC) is a newly defined entity among salivary
gland malignancies which has just been established in the 4th edition of the WHO …

Purpose At present, perineural invasion is used as a histologic indicator of aggressive
salivary gland disease. In other head and neck malignancies, perineural invasion impacts …

Background This study investigated the effects of adjuvant radiotherapy on outcomes in
early‐stage major salivary gland cancers. Methods A total of 655 patients were identified …

Objective Salivary squamous cell carcinomas (SCCs) represent a unique disease entity
because many are thought to represent metastases from primary cutaneous malignancies …

Head and neck cancers, as well as the therapies used to treat them, may result in
considerable and long-term disabilities that decrease the patients' quality of life. Thus …

Purpose We evaluated the impact of various tumor related parameters on survival
probability in a cohort of patients with malignant salivary tumors, using the Kaplan–Meier …

Background Risk stratification and appropriate treatment selection are essential for the
management of head and neck malignancies, in order to optimize long-term outcomes …

Simple Summary Postoperative radiotherapy (PORT) was strongly recommended for major
salivary gland malignancies (SGM) with adverse features. However, distant metastasis (DM) …